VivoSim Labs VIVS
NASDAQ VIVS
$0.26 0.00 (-0.27%)
As of: Sep 17, 2026 · 3:59 PM EDT

VivoSim Labs (VIVS) Cash from Operations (2010 - 2026)

VivoSim Labs (VIVS) posted Cash from Operations of -$3.2 million for Q2 2026, down 44.27% on a QoQ basis from -$2.2 million in Q1 2026, and up 18.45% year-over-year from -$2.7 million in Q2 2025.

Analysis

VivoSim Labs (VIVS) Cash from Operations (2010 - 2026) Analysis & Trends

VivoSim Labs has reported Cash from Operations for 17 years, with the latest figure at -$3.2 million in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 18.45% year-over-year to -$3.2 million in Q2 2026; TTM through Jun 2026 was -$10.1 million, a 3.05% increase from a year earlier, with the FY2026 full-year figure at -$10.8 million, down 14.44% from the prior year.
  • Cash from Operations was -$3.2 million for Q2 2026 at VivoSim Labs, down from -$2.2 million in the prior quarter.
  • The five-year high for Cash from Operations was -$1.5 million in Q1 2022, with the low at -$5.3 million in Q2 2023.
  • Average Cash from Operations over 5 years is -$2.9 million, with a median of -$2.7 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 207.14% in 2023, then jumped 48.86% in 2024.
  • Over 5 years, Cash from Operations stood at -$3.0 million in 2022, then decreased by 15.7% to -$3.5 million in 2023, then surged by 48.86% to -$1.8 million in 2024, then declined by 26.71% to -$2.3 million in 2025, then plunged by 40.8% to -$3.2 million in 2026.
  • The last three Cash from Operations figures came in at -$3.2 million (Q2 2026), -$2.2 million (Q1 2026), and -$2.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 162.01 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 281.27 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 179.73 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 28.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -44.27 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -492,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.90 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.21 Mn
Mar 31, 2026 -2.23 Mn
Dec 31, 2025 -2.28 Mn
Sep 30, 2025 -2.38 Mn
Jun 30, 2025 -3.94 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 -1.80 Mn
Sep 30, 2024 -2.64 Mn
Jun 30, 2024 -2.98 Mn
Mar 31, 2024 -2.67 Mn
Dec 31, 2023 -3.52 Mn
Sep 30, 2023 -3.15 Mn
Jun 30, 2023 -5.31 Mn
Mar 31, 2023 -4.73 Mn
Dec 31, 2022 -3.04 Mn
Sep 30, 2022 -2.22 Mn
Jun 30, 2022 -2.41 Mn
Mar 31, 2022 -1.54 Mn
Dec 31, 2021 -3.36 Mn
Sep 30, 2021 -2.14 Mn